Pharma stock jumps 7% after NCLT approves OneSource India’s first specialty pharma CDMO

During Thursday’s trading session, the shares of a global pharmaceutical company headquartered in Bengaluru surged 7.7 percent to Rs. 1,499.9 on BSE, after the company received approval from NCLT for the creation of OneSource, India’s first specialty pharma CDMO.  With a market cap of Rs. 13,737.2 crores, at 02:37 p.m., the shares of Strides Pharma … Continue reading Pharma stock jumps 7% after NCLT approves OneSource India’s first specialty pharma CDMO